CD70 and PD-L1 (CD274) co-expression predicts poor clinical outcomes in patients with pleural mesothelioma

March 15, 2023 | Comments Off on CD70 and PD-L1 (CD274) co-expression predicts poor clinical outcomes in patients with pleural mesothelioma

The Journal of Pathology. Clinical Research 2023 February 8 [Link] Shingo Inaguma, Akane Ueki, Jerzy Lasota, Masayuki Komura, Asraful Nahar Sheema, Piotr Czapiewski, Renata Langfort, Janusz Rys, Joanna Szpor, Piotr…

Long-Term Survival in Patients Treated with Cytoreduction and Heated Intraperitoneal Chemotherapy for Peritoneal Mesothelioma at a Single High-Volume Center

March 14, 2023 | Comments Off on Long-Term Survival in Patients Treated with Cytoreduction and Heated Intraperitoneal Chemotherapy for Peritoneal Mesothelioma at a Single High-Volume Center

Annals of Surgical Oncology 2023 February 8 [Link] Cristian D Valenzuela, Ian B Solsky, Richard A Erali, Steven D Forsythe, Christopher W Mangieri, Bigyan B Mainali, Gregory Russell, Kathleen C…

Pleurectomy and decortication are associated with better survival for bicavitary cytoreductive surgery for mesothelioma compared with extrapleural pneumonectomy

March 13, 2023 | Comments Off on Pleurectomy and decortication are associated with better survival for bicavitary cytoreductive surgery for mesothelioma compared with extrapleural pneumonectomy

Journal of Thoracic and Cardiovascular Surgery 2022 December 14 [Link] R Taylor Ripley, Hudson M Holmes, Richard S Whitlock 2, Shawn S Groth, Cristian G Medina, Eugene A Choi, Bryan…

Importance of Histopathological Grading for Treatment Selection in Malignant Mesothelioma

March 10, 2023 | Comments Off on Importance of Histopathological Grading for Treatment Selection in Malignant Mesothelioma

The Thoracic and Cardiovascular Surgeon 2023 February 3 [Link] İlteriş Türk, Gokturk Findik, Mehmet Çetin, Pinar Bicakcioglu, Selim Şakir Erkmen Gülhan, Koray Aydoğdu, Ülkü Yılmaz, Funda Demirağ Abstract Background: Complexities…

Tumor thickness in mesothelioma predicts differential response to neoadjuvant therapy and survival

March 9, 2023 | Comments Off on Tumor thickness in mesothelioma predicts differential response to neoadjuvant therapy and survival

The Journal of Thoracic and Cardiovascular Surgery 2022 December 14 [Link] Nicolas Zhou, Cynthia S Bell, Hope A Feldman, Cara L Haymaker, Wayne L Hofstetter, Anne S Tsao, Reza J…

Micro-Fragmented Fat Inhibits the Progression of Human Mesothelioma Xenografts in Mice

March 8, 2023 | Comments Off on Micro-Fragmented Fat Inhibits the Progression of Human Mesothelioma Xenografts in Mice

Current Cancer Drug Targets 2023 February 1 [Link] Silvia La Monica, Valentina Coccé, Mara Bonelli, Giulio Alessandri, Roberta Alfieri, Costanza Annamaria Lagrasta, Caterina Frati, Lisa Flammini, Aldo Gianni, Francesco Petrella,…

miR-142-3p Suppresses Invasion and Adhesion of Mesothelioma Cells by Downregulating ITGAV

March 7, 2023 | Comments Off on miR-142-3p Suppresses Invasion and Adhesion of Mesothelioma Cells by Downregulating ITGAV

Pathobiology 2023 Febrary 1 [Link] Ihiro Endo, Vishwa Jeet Amatya, Kei Kushitani Tetsuya Nakagiri, Kohei Aoe, Yukio Takeshima Abstract Introduction: Malignant mesothelioma is an aggressive cancer associated with asbestos exposure.…

The Predictive Value of ERCC1, RRM1, and Thymidylate Synthase in Advanced Malignant Pleural Mesothelioma Patients Treated with Platinum-Based Chemotherapy

March 6, 2023 | Comments Off on The Predictive Value of ERCC1, RRM1, and Thymidylate Synthase in Advanced Malignant Pleural Mesothelioma Patients Treated with Platinum-Based Chemotherapy

Asian Pacific Journal of Cancer Prevention 2023 January 1 [Link] Nagwa Ismail Wahba, Ola Khorshid, Fatma Abo Elkasem, Abeer Bahnassy, Rabab Gaafer Abstract Background: A rare yet severe neoplasia called…

Correlation of serum-soluble mesothelin-related protein, HMGB1 and CA125 in diffuse malignant peritoneal mesothelioma and their combined measurement for prognosis

March 3, 2023 | Comments Off on Correlation of serum-soluble mesothelin-related protein, HMGB1 and CA125 in diffuse malignant peritoneal mesothelioma and their combined measurement for prognosis

Scandinavian Journal of Clinical and Laboratory Investigation 2023 January 27 [Link] Lianfen Wang, Xuesong Wang, Ningning Sun, Baosheng Chen Abstract Diagnosis of diffuse malignant peritoneal mesothelioma (DMPM) is challenging due…

A molecular phenotypic map of malignant pleural mesothelioma

March 2, 2023 | Comments Off on A molecular phenotypic map of malignant pleural mesothelioma

GigaScience 2022 December 28 [Link] Alex Di Genova, Lise Mangiante, Alexandra Sexton-Oates, Catherine Voegele, Lynnette Fernandez-Cuesta, Nicolas Alcala, Matthieu Foll Abstract Background: Malignant pleural mesothelioma (MPM) is a rare understudied…

Categories